HLS Therapeutics Inc. (FRA:74D)

HLS Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.78	17.46	21.95	20.72	21.18	20.61
Cash & Short-Term Investments	10.78	17.46	21.95	20.72	21.18	20.61
Cash Growth	-38.55%	-20.48%	5.93%	-2.15%	2.75%	-56.22%
Accounts Receivable	7.72	6.72	9.64	8.91	9.77	10.92
Other Receivables	0.51	0.8	1.05	2.29	1.74	1.58
Receivables	8.22	7.53	10.69	11.19	11.51	12.5
Inventory	7.11	9.06	9.53	8.9	8.93	10.63
Prepaid Expenses	-	1.36	1.91	2.13	2.14	2.17
Other Current Assets	1.39	-	0	1.43	-	-
Total Current Assets	27.49	35.4	44.1	44.37	43.75	45.91
Property, Plant & Equipment	1.27	1	0.97	1.13	1.57	1.38
Other Intangible Assets	109.68	122.12	162.34	195.02	229.18	253.4
Long-Term Deferred Tax Assets	1.25	0.86	1.04	0.47	0.69	1.17
Other Long-Term Assets	0.55	0.53	0.62	0.67	0.71	2.03
Total Assets	140.23	159.9	209.06	241.65	275.91	303.91
Accounts Payable	10.59	8.71	14.11	11.59	9.32	9.18
Accrued Expenses	-	-	-	-	-	3.79
Current Portion of Long-Term Debt	4.26	4.83	4.69	13.06	12	9.75
Current Portion of Leases	0.5	0.46	0.46	0.53	0.61	0.39
Current Income Taxes Payable	0.39	0.15	0.28	-	0.1	0.55
Other Current Liabilities	7.73	8.4	7.14	6.02	5.65	11.98
Total Current Liabilities	23.46	22.55	26.69	31.19	27.67	35.64
Long-Term Debt	48.83	60.74	82.05	83.28	84.13	98.24
Long-Term Leases	0.5	0.43	0.42	0.48	0.83	0.78
Long-Term Deferred Tax Liabilities	3.92	4.07	0.44	0.57	0.65	-
Other Long-Term Liabilities	1.77	0.78	1.77	0.82	1.88	-
Total Liabilities	78.49	88.56	111.36	116.33	115.17	134.66
Common Stock	256.35	260.6	262.13	265.21	265.92	257.41
Additional Paid-In Capital	15.91	15.14	13.87	13.82	11.72	11.39
Retained Earnings	-202.82	-194.18	-175.46	-148.45	-119.86	-101.58
Comprehensive Income & Other	-7.7	-10.21	-2.84	-5.26	2.96	2.02
Shareholders' Equity	61.74	71.34	97.7	125.32	160.74	169.25
Total Liabilities & Equity	140.23	159.9	209.06	241.65	275.91	303.91
Total Debt	54.09	66.45	87.62	97.35	97.57	109.16
Net Cash (Debt)	-43.31	-48.99	-65.67	-76.62	-76.39	-88.55
Net Cash Per Share	-1.37	-1.54	-2.04	-2.36	-2.37	-2.79
Filing Date Shares Outstanding	31.27	31.79	31.92	32.35	32.47	31.99
Total Common Shares Outstanding	31.28	31.79	31.98	32.36	32.45	31.82
Working Capital	4.04	12.86	17.41	13.18	16.08	10.27
Book Value Per Share	1.97	2.24	3.05	3.87	4.95	5.32
Tangible Book Value	-47.94	-50.78	-64.65	-69.7	-68.45	-84.16
Tangible Book Value Per Share	-1.53	-1.60	-2.02	-2.15	-2.11	-2.64
Machinery	-	1.18	1.17	1.12	1.08	1.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.